Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Depreciation & Amortization (CF) (2016 - 2021)

Historic Depreciation & Amortization (CF) for Neurocrine Biosciences (NBIX) over the last 12 years, with Q4 2021 value amounting to $3.0 million.

  • Neurocrine Biosciences' Depreciation & Amortization (CF) rose 3636.36% to $3.0 million in Q4 2021 from the same period last year, while for Dec 2021 it was $10.9 million, marking a year-over-year increase of 2674.42%. This contributed to the annual value of $23.5 million for FY2024, which is 3202.25% up from last year.
  • According to the latest figures from Q4 2021, Neurocrine Biosciences' Depreciation & Amortization (CF) is $3.0 million, which was up 3636.36% from $2.8 million recorded in Q3 2021.
  • In the past 5 years, Neurocrine Biosciences' Depreciation & Amortization (CF) registered a high of $3.0 million during Q4 2021, and its lowest value of $489000.0 during Q1 2017.
  • For the 5-year period, Neurocrine Biosciences' Depreciation & Amortization (CF) averaged around $1.7 million, with its median value being $1.9 million (2019).
  • In the last 5 years, Neurocrine Biosciences' Depreciation & Amortization (CF) soared by 10226.5% in 2019 and then surged by 950.72% in 2020.
  • Over the past 5 years, Neurocrine Biosciences' Depreciation & Amortization (CF) (Quarter) stood at $706000.0 in 2017, then surged by 80.59% to $1.3 million in 2018, then soared by 56.86% to $2.0 million in 2019, then rose by 10.0% to $2.2 million in 2020, then surged by 36.36% to $3.0 million in 2021.
  • Its Depreciation & Amortization (CF) stands at $3.0 million for Q4 2021, versus $2.8 million for Q3 2021 and $2.6 million for Q2 2021.